Albert Font - Concepedia

Author

Albert Font

Hospital Universitari Germans Trias i Pujol

Also Known As

A FONT, A Font, A. FONT, A. Font, Albert Font, Allison R. Font, Carolyn Fox, Juan F. García

110

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitari Germans Trias i Pujol Institut Català d'Oncologia Hospital Del Mar Corporació Sanitària Parc Taulí Hospital Clínico San Carlos

About

Albert Font is an author at Hospital Universitari Germans Trias i Pujol specializing in medicine, oncology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	875
2	Health Sciences	4	4	76
3	Education	1	1	44
4	Cell Biology	1	1	36
5	Diagnostic Sciences	1	1	17

Albert Font

Publications

Citations

H-Index

Page 1

	Year	Citations
A Novel Anti-Apoptosis Gene: Re-expression of Survivin Messenger RNA as a Prognosis Marker in Non–Small-Cell Lung Cancers Mariano Monzó, Rafael Rosell, Enriqueta Felip, Journal of Clinical Oncology	1999	496
Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study Jesús García-Donás, Emilio Esteban, Luis J. Leandro‐García, The Lancet Oncology UrologyGenitourinary CancerMedicineToxic EffectsAdvanced Renal-cell Carcinoma	2011	220
Phase I-II Study of Paclitaxel, Cisplatin, and Gemcitabine in Advanced Transitional-Cell Carcinoma of the Urothelium Joaquim Bellmunt, Vicente Guillém, Luis Paz‐Ares, Journal of Clinical Oncology	2000	191
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study Arlene O. Siefker‐Radtke, Andrea Necchi, Se Hoon Park, The Lancet Oncology UrologyOncologyMetastatic Urothelial CarcinomaGenitourinary CancerCancer Management	2022	162
Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract Miquel Nogué‐Aliguer, Joan Carles, A. Arriví, Cancer	2003	98
Identification of Tissue microRNAs Predictive of Sunitinib Activity in Patients with Metastatic Renal Cell Carcinoma Celia Prior, José Luis Perez‐Gracia, Jesús García-Donás, PLoS ONE	2014	81
Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma Jesús García-Donás, Luis J. Leandro‐García, Aranzazu González del Alba, Annals of Oncology	2013	73
Reduced survival in patients with stage-I non-small-cell lung cancer associated with DNA-replication errors Rafael Rosell, Àlex Pifarré, Mariano Monzó, International Journal of Cancer	1997	64
Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer Joan Carles, Emilio Esteban, Albert Font, Annals of Oncology Metastatic Urothelial CancerUrologyGenitourinary CancerMedicineOxaliplatin Combination	2007	58
Pericardial mesothelioma in a dog: long‐term survival after pericardiectomy in combination with chemotherapy Josep Maria Closa, Albert Font, J. Mascort Journal of Small Animal Practice	1999	50

Page 1